Diterpenes | Jotup

The HydraFacial® Company Launches New Booster with Murad®

Retrieved on:

Monday, January 11, 2021

Vitamins, Chemical compounds, Antioxidants, Diterpenes, Retinol, Skin care, Organic compounds, Chemical substances

Through the exciting new partnership, Murad and HydraFacial are launching Murad Retinol Booster for HydraFacial.

Key Points:

Through the exciting new partnership, Murad and HydraFacial are launching Murad Retinol Booster for HydraFacial.
Inspired by Murad's Retinol Youth Renewal Serum, the No.1 Retinol product in the U.S.*, the Murad Retinol Booster is the first retinol-based booster developed for HydraFacial devices and available to professional skincare providers.
"We're excited to expand our portfolio of customized treatment solutions with the Murad Retinol Booster for HydraFacial," said Clint Carnell, Chief Executive Officer of The HydraFacial Company.
Our combination of a fast-acting retinol, time-released retinol and a retinol booster deliver powerful skin renewal without the traditional effects of retinol.

QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

Retrieved on:

Wednesday, November 18, 2020

Chemical compounds, Organic compounds, Chemistry, Alcohols, Cyclopropanes, Diterpenes, Epoxides, Ketones, Tigilanol tiglate, Mastocytoma

The efficacy and durability of response data in dogs with mast cell tumours are very promising.

Key Points:

The efficacy and durability of response data in dogs with mast cell tumours are very promising.
While surgery will remain the mainstay, I do think STELFONTA will reshape how we approach local mast cell tumour control in many ways."
Dr Victoria Gordon, CEO and Managing Director of QBiotics, said, "FDA approval is a pivotal achievement for both STELFONTA and QBiotics.
Randomized controlled clinical study evaluating the efficacy and safety of intratumoural treatment of canine mast cell tumours with tigilanol tiglate (EBC-46).

QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

Retrieved on:

Wednesday, November 18, 2020

Chemical compounds, Organic compounds, Chemistry, Alcohols, Cyclopropanes, Diterpenes, Epoxides, Ketones, Tigilanol tiglate, Mastocytoma

The efficacy and durability of response data in dogs with mast cell tumours are very promising.

Key Points:

The efficacy and durability of response data in dogs with mast cell tumours are very promising.
While surgery will remain the mainstay, I do think STELFONTA will reshape how we approach local mast cell tumour control in many ways."
Dr Victoria Gordon, CEO and Managing Director of QBiotics, said, "FDA approval is a pivotal achievement for both STELFONTA and QBiotics.
Randomized controlled clinical study evaluating the efficacy and safety of intratumoural treatment of canine mast cell tumours with tigilanol tiglate (EBC-46).

Information update - LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer

Retrieved on:

Tuesday, October 27, 2020

Organic compounds, Chemical compounds, Chemistry, Cyclopropanes, Diterpenes, Ingenol mebutate, Ketones, Triols

What to do: Stop your treatment and talk to your healthcare professional about other treatment options.

Key Points:

What to do: Stop your treatment and talk to your healthcare professional about other treatment options.
Monitor your skin for signs or symptoms of skin cancer.
At Health Canada's request, LEO Pharma Inc. is withdrawing Picato from the Canadian market.
On October 26, 2020, LEO Pharma Inc. initiated the recall of Picato from the Canadian market.

Global Gibberellins Market to Reach USD 1.42 Billion by 2027 | Reports And Data

Retrieved on:

Tuesday, June 23, 2020

Plants, Organisms, Plant reproduction, Plant hormones, Berries, Agronomy, Diterpenes, Gibberellin, Grape, Seed, Fruit

NEW YORK, June 23, 2020 /PRNewswire/ -- The global gibberellins market is expected to reach USD 1.42 Billion by 2027, according to a new report by Reports and Data.

Key Points:

NEW YORK, June 23, 2020 /PRNewswire/ -- The global gibberellins market is expected to reach USD 1.42 Billion by 2027, according to a new report by Reports and Data.
Gibberellins aids in promoting flowering by increasing the rate of growth of flowers, which, in turn, has a substantial effect on the growth rate of fruits.
Gibberellins find usage in producing seedless fruit, including seedless grapes, which are usually sprayed with gibberellin to improve the size of each grape.
For the purpose of this report, Reports and Data have segmented the global gibberellins market on the basis of method, type, distribution channel, application, and region:

Global Gibberellins Market to Reach USD 1.42 Billion by 2027 | Reports And Data

Retrieved on:

Tuesday, June 23, 2020

Plants, Plant reproduction, Academic disciplines, Organisms, Berries, Agronomy, Diterpenes, Gibberellin, Grape, Compound annual growth rate, Seed, Economic growth

Market Size USD 718.6 million in 2019, Market Growth - CAGR of 8.8%, Market Trends Growth of the brewing industry

Key Points:

Market Size USD 718.6 million in 2019, Market Growth - CAGR of 8.8%, Market Trends Growth of the brewing industry
NEW YORK, June 23, 2020 /PRNewswire/ -- The global gibberellins market is expected to reach USD 1.42 Billion by 2027, according to a new report by Reports and Data.
Gibberellins aids in promoting flowering by increasing the rate of growth of flowers, which, in turn, has a substantial effect on the growth rate of fruits.
Gibberellins find usage in producing seedless fruit, including seedless grapes, which are usually sprayed with gibberellin to improve the size of each grape.
For the purpose of this report, Reports and Data have segmented the global gibberellins market on the basis of method, type, distribution channel, application, and region:

Global Gibberellins Global Market Drivers, Restraints, Threats & Opportunities During the Forecast Period, 2018-2027 - ResearchAndMarkets.com

Retrieved on:

Tuesday, January 21, 2020

Chemicals, Plastics, Agriculture, Natural Resources, Manufacturing, Agronomy, Diterpenes, Gibberellin, Marketplace

The Global Gibberellins market accounted for a CAGR of 11.2% during the forecast period.

Key Points:

The Global Gibberellins market accounted for a CAGR of 11.2% during the forecast period.
Some of the key factors propelling the market growth are rising demand for agricultural production and growing consumption of fruits across the globe.
By application, fruit production segment is expected to grow at the significant market share during the forecast period.
Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
Company profiling with detailed strategies, financials, and recent developments